Analyst Ratings January 29, 2026

BMO Lowers HubSpot Target to $385, Cites SMB Weakness Even as Analysts Split on Outlook

Brokerage trims price objective amid softer SMB data and December-quarter growth concerns while keeping an Outperform rating

By Jordan Park HUBS
BMO Lowers HubSpot Target to $385, Cites SMB Weakness Even as Analysts Split on Outlook
HUBS

BMO Capital reduced its price target for HubSpot Inc (HUBS) to $385 from $465 and kept an Outperform rating, pointing to limited upside to consensus billings and revenue in the December quarter and modest deterioration in small and medium-sized business (SMB) conditions. Other brokerages maintain bullish ratings with a range of price targets, reflecting a mix of strong historical growth and nearer-term demand uncertainty.

Key Points

  • BMO Capital cut its HubSpot price target to $385 from $465 but maintained an Outperform rating.
  • BMO cited reduced upside to consensus billings and revenue in the December quarter and noted a modest net deterioration in SMB conditions.
  • Other analysts issued mixed yet generally bullish views with price targets ranging from $500 to $660 and Buy/Outperform ratings.

BMO Capital has cut its target price on HubSpot Inc (NYSE: HUBS) to $385.00 from $465.00 while retaining an Outperform rating, saying it now sees less upside to consensus billings and revenue growth in the December quarter than it had previously anticipated. The new target still sits noticeably above the shares' recent trading level of $290.48, with the stock trading near its 52-week low after sliding more than 59% over the past year.

Despite the price-target reduction, BMO highlighted that HubSpot has delivered solid revenue expansion recently, recording revenue growth of 19.21% over the last twelve months. Nonetheless, the firm flagged a softening signal from several SMB-focused data sources, which collectively point to a modest net deterioration in SMB conditions that could constrain HubSpot's near-term demand for its platform.

As a result of these readings, BMO now expects management to guide fiscal year 2026 revenue growth to a range of 14% to 15% year-over-year on a constant currency basis. The brokerage also reiterated concerns that continuing uncertainty around generative artificial intelligence is weighing on the application segment, though it said these AI-related worries did not change its overall positive view and Outperform recommendation on the stock.

The move from BMO comes amid a cluster of other analyst updates that present a mixed but generally constructive view of HubSpot's longer-term prospects. Stifel lowered its price target to $500 but kept a Buy rating, citing software multiple compression as a driver of valuation pressure. Raymond James maintained an Outperform view and a $525 price target, pointing to robust growth that exceeded management's plans for 2025.

Citi kept a Buy rating and set a $660 price target while placing HubSpot on a 30-day upside catalyst watch. Oppenheimer continued to rate HubSpot as Outperform with a $550 target, despite noting mixed demand signals and reporting a shortfall in fourth-quarter new monthly recurring revenue.

That shortfall in new monthly recurring revenue was attributed by analysts to a few discrete factors: reduced upmarket deal flow and a smaller-than-expected budget flush. Some of the deals that were expected in the quarter were reportedly postponed into the first quarter of fiscal 2026, yet Raymond James observed that growth targets were still met in the period overall.

The collection of analyst reactions illustrates divergent emphasis across valuation, growth trajectory and near-term demand indicators. BMO trimmed its upside expectations on the December quarter based on SMB readings and held back its price target accordingly, while other brokerages continued to assign materially higher targets based on longer-term growth momentum and different interpretations of recent quarterly results.

For investors, the headlines reflect a tension between HubSpot's recent double-digit revenue growth and near-term demand noise concentrated among small and medium-sized customers and in certain enterprise deal flows. BMO's reduced target signals a more cautious near-term posture tied to SMB health and December-quarter billings, even as the firm remains constructive on the shares relative to the market.

Risks

  • Near-term revenue and billings could underperform expectations if SMB conditions continue to weaken - impacts software vendors and business services sectors.
  • Shortfalls in new monthly recurring revenue due to reduced upmarket deal flow and limited budget flush may pressure subscription-centric business models - impacts enterprise SaaS vendors and cloud software markets.
  • Uncertainty around generative AI demand dynamics could weigh on the application segment and investor sentiment toward software multiples - impacts technology and AI-focused software providers.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026